新闻中心 - Nordic BioSite中国区代理商/公司/官网

欢迎来到 Nordic BioSite中国区代理商/公司/官网

全国咨询热线： 13212737804

Nordic BioSite中国区代理商/公司/官网

产品中心

推荐产品

invivoCrown IV0114替换BioXCell BE0213

invivoCrown IV0118替换BioXCell BE0055

联系我们

地址：武汉市洪山区光谷大道35号光谷总部国际时代二期1栋1301

电话：15172431432

传真：17754422825

邮箱：sales@amyjet.com

新闻中心

首页 > 新闻中心

艾美捷科技代理Ocean Nanotech品牌纳米材料。

Ocean Nanotech, LLC专注于纳米材料、纳米技术及其生物医学应用。Ocean Nanotech公司技术特点在于：采用先进的合成技术，确保纳米材料的高纯度和高稳定性；多功能应用: 纳米材料具有广泛的应用前景，包括生物医学、光学、电子学等领域；定制化服务: 提供灵活的定制纳米材料设计和生产服务，满足客户需求。Ocean Nanotech公司纳米材料应用广泛，包括生物标记、细胞成像、药物传递和癌症治疗；光学传感器、光催化和光学成像；用于电子器件、传感器和导电材料；用于环境监测和污染治理。

Ocean Nanotech公司产品包括：

（1）纳米颗粒：提供多种纳米颗粒，包括金纳米颗粒、银纳米颗粒、量子点等，用于生物医学、光学和电子学应用。

（2）纳米材料试剂盒：提供用于生物标记、细胞成像和药物传递的纳米材料试剂盒。

（3）定制纳米材料：根据客户需求，提供定制化的纳米材料设计和生产服务。

（4）纳米技术咨询服务：提供纳米技术相关的咨询和技术支持服务。

<<< " data-original="http://nordic.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Ocean Nanotech品牌纳米材料"> 艾美捷科技代理Ocean Nanotech品牌纳米材料

...

阅读详情

Alamanda Polymers是世界领先的多聚氨基酸生产商，其主要产品为多聚寡氨基酸链以及PEG化的多聚氨基酸链。其拥有独特的多聚化工艺，是唯一能够提供确切的聚合数值多聚氨基酸的公司，能够使研究者的实验结果更加具有可重复性。

Alamanda Polymers specializes in the manufacturing of well-defined polyamino acids for research laboratories doing work in gene therapy, encapsulation, drug delivery, cell adhesion, and surface coating. Our company provides a wide range of metal-free biopolymers including homopolyamino acids and PEGylated polyamino acids. Due to our characteristic polymerization process, we are the only supplier able to offer effectually exact polyamino acid chain lengths thereby giving researchers new options for use and consistently reproducible results.

Alamanda Polymer has more than 15 years experience in the synthesis of polyamino acids, has developed a polymerization process that enables them to have complete control over the molecular weight of our polyamino acids without the use of metal catalysts. Furthermore, not only does the process enable us to achieve effectually exact chain lengths but also highly monomodal products (polydispersity index: 1.01-1.2) and batch-to-batch consistency.

产品包括：

Side-Functionalized Homopolyamino Acids

Poly-L-lysine

Poly-L-glutamic acid

End-Functionalized Homopolyamino Acids

Poly-L-lysine

Poly-L-glutamic acid

Poly-L-arginine

Homopolyamino Acids

Poly-L-lysine

Poly-D-lysine

Poly-D,L-lysine

Poly-L-ornithine

Poly-L-homoarginine

Poly-L-arginine

Poly-L-glutamic acid

Poly-D-glutamic acid

Poly-D,L-glutamic acid

Poly-L-aspartic acid

PEGylated Polyamino Acids

PEG-b-poly-L-lysine

N3-PEG-b-poly-L-lysine

PEG-b-poly-L-glutamic acid

N3-PEG-b-poly-L-glutamic acid

PEG-b-poly-L-aspartic acid

Poly(L-Lys)-b-PEG-b-poly(L-Lys)

Poly(L-Glu)-b-PEG-b-poly(L-Glu)

Poly(L-Asp)-b-PEG-b-poly(L-Asp)

Custom Polyamino Acids

Poly-L-lysine

Poly-D-lysine

Poly-L-glutamic acid

Poly-D,L-glutamic acid

Poly-L-arginine

PEG-b-poly-L-lysine

PEG-b-poly-D-lysine

PEG-b-poly-L-glutamic acid

PEG-b-poly-L-aspartic acid

Poly(L-Glu)-b-PEG-b-poly(L-Glu)

Polyamino Acids For Cell Culture

Poly-L-lysine

Poly-D-lysine

Poly-L-ornithine

" data-original="http://nordic.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Alamanda Polymers"> Alamanda Polymers

...

阅读详情

艾美捷科技代理Berry & Associates全系列修饰核苷酸等

美国 Berry & Associates 公司成立于1989年，提供近200种亚磷酰胺和核苷酸合成用固相交联单体，以及数百种核苷、核苷酸、糖类、荧光标记物、淬灭剂和杂环化合物。

Founded in 1989 with roots in the nucleoside field, Berry & Associates soon moved into the chemistry of nucleic acids, resulting in a current portfolio of nearly 200 phosphoramidites and solid phase-linked monomers for oligonucleotide synthesis as well as hundreds of nucleosides, nucleotides, carbohydrates, spacers, fluorescent markers, quenchers, and heterocycles - all proudly made at our facility just outside of Ann Arbor, Michigan. Although our company is small, the credentials of our highly trained staff of chemists include over 400 publications and 80 patents in synthetic organic and medicinal chemistry. High quality chemicals, timeliness, and personalized service are the hallmarks of Berry & Associates.

Berry & Associates的主要产品包括：

产品名称	产品编号	纯度	规格
2',3'-Dideoxyadenosine	PR 3495	≥95%	25 mg; 100 mg
2'-3'-Dideoxyguanosine	PR 3505	≥95%	25 mg; 100 mg
2',3'-Dideoxyinosine	PR 3727	≥97%	100 mg; 1 g
3'-Deoxythymidine	PY 7277	≥95%	50 mg; 100 mg
2',3'-Dideoxyuridine	PY 7278	≥97%	100 mg; 500 mg
2',3'-Didehydro-2',3'-dideoxyuridine	PY 7279	≥97%	25 mg; 100 mg
2',3'-Dideoxycytidine	PY 7325	≥95%	50 mg; 100 mg
2-Aminoadenosine (2,6-Diaminopurine riboside)	PR 3030	≥97%	2 g; 10 g
2-Amino-2'-deoxyadenosine	PR 3060	≥97%	1 g; 5 g
2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-deoxyadenosine	PR 3080	≥95%	100 mg; 1 g
2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine	PR 3090	≥97%	250 mg; 1 g
2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine	PR 3110	≥95%	250 mg; 1 g
2-Amino-N2-isobutyryl-2'-deoxyadenosine	PR 3130	≥95%	100 mg; 1 g
2-Amino-N2-O-methyladenosine	PR 3150	≥97%	1 g; 10 g
2-(Dimethylaminomethylidene)amino-6-methoxylamino-9-(β-D-2-deoxyribofuranosyl)purine	PR 3670	≥95%	100 mg; 1 g
2-Amino-9-(β-D-2'-deoxyribfuranosyl)purine	PR 3070	≥97%	25 mg; 100 mg
2-Amino-9-(2-O-methyl-β-D-ribofuranosyl)purine	PR 3160	≥97%	100 mg; 250 mg
2-Amino-9-(β-D-ribofuranosy)purine Hemihydrate	PR 3180	≥97%	25 mg; 100 mg
2-(Dimethylaminomethylidene)amino-9-(β-D-2-deoxyribofuranosyl)purine	PR 3680	≥97%	100 mg; 1 g
6-N-Acyl-6-N-methyl-2'-deoxyadenosine	PR 3006	≥95%	25 mg; 100 mg
8-Amino-2'-deoxyadenosine	PR 3115	≥97%	10 mg; 100 mg
N6-(6-Aminohexyl)-2'-deoxyadenosine	PR 3120	≥90%	100 mg; 1 g
8-Azido-2'-deoxyadenosine	PR 3125	≥97%	10 mg; 100 mg
N6-Benzoyl-8-benzyloxy-2'-deoxyadenosine	PR 3230	≥95%	50 mg; 250 mg
N6-Benzoyl-5'-O-(dimethoxytrityl)-8-oxo-2'-deoxyadenosine	PR 3260	≥95%	100 mg; 1 g
N6-Benzoyl-8-oxo-2'-deoxyadenosine	PR 3270	≥97%	100 mg; 1 g
8-Benzyloxy-2'-deoxyadenosine	PR 3280	≥97%	100 mg; 1 g
8-Bromo-2'-deoxyadenosine	PR 3290	≥90%	2 g; 10 g
8-Bromo-N6-(dimethylaminomethylidene)-2'-deoxyadenosine	PR 3320	≥95%	100 mg; 1 g
8-Bromo-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-2'-deoxyadenosine	PR 3340	≥97%	0g (discontinued);
2'-Deoxyadenosine Monohydrate	PR 3445	≥97%	25 g; 100 g
2',3'-Dideoxyadenosine	PR 3495	≥95%	25 mg; 100 mg
2-Fluoro-2'-deoxyadenosine	PR 3496	≥97%	25 mg; 1 g
8-Oxo-2'-deoxyadenosine	PR 3705	≥95%	25 mg; 250 mg
N6-Methyl-2'-deoxyadenosine	PR 3740	≥97%	100 mg; 1 g
4-Chloro-1-(2-deoxy-β-D-ribofuranosyl)-7-methyl-1H-imidazo[4,5-c]pyridine	PRA 10012	≥95%	10 mg; 50 mg
3-Deaza-3-methyl-2'-deoxyadenosine	PRA 10013	≥97%	10 mg; 25 mg
5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosine	PRA 10019	≥97%	500 mg; 1 g
7-(3-Nitrophenyl)-7-deaza-2'-deoxyadenosine	PRA 10032	≥95%	10 mg; 50 mg
5-Iodo-2'-deoxytubercidin	PRA 10036	≥95%	10 mg; 50 mg
8-Allyloxy-2'-deoxyguanosine	PR 3010	≥90%	0Discontinued;
8-Allyloxy-N2-(dimethylaminomethylidene)-2'-deoxyguanosine	PR 3015	≥90%	1 g; 10 g
8-Allyloxy-N2-isobutyryl-2'-deoxyguanosine	PR 3020	≥90%	1 g; 10 g
5'-Azido-5'-deoxyguanosine	PR 3225	≥90%	5 mg; 10 mg
8-Benzyloxy-N2-isobutyryl-2'-deoxyguanosine	PR 3285	≥90%	1 g; 10 g
8-Bromo-2'-deoxyguanosine	PR 3300	≥90%	1 g; 5 g
8-Bromo-5'-O-(dimethyoxytrityl)-N2-(dimethyl-aminomethylidene)-2'-deoxyguanosine	PR 3310	≥97%	500 mg; 1 g
8-Bromo-N2-(dimethylaminomethylidene)-2'-deoxyguanosine	PR 3330	≥90%	250 mg; 1 g
5'-O-Dimethoxytrityl-N2-(dimethylaminomethylidene)-8-ethenyl-2'-deoxyguanosine	PR 3335	≥95%	100 mg; 1 g
2'-Deoxyguanosine monohydrate	PR 3452	≥97%	10 g; 100 g
α-2'-Deoxyguanosine	PR 3455	≥97%	10 mg; 100 mg
2'-Deoxyisoguanosine	PR 3465	≥97%	10 mg; 100 mg
5'-O-(Dimethoxytrityl)-N2-ethyl-2'-deoxyguanosine	PR 3600	≥97%	100 mg; 1 g
3',5'-Di-O-acetyl-2'-deoxyguanosine	PR 3605	≥97%	500 mg; 1 g
5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosine	PR 3610	≥97%	100 mg; 1 g
5'-O-(Dimethoxytrityl)-N2-methyl-2'-deoxy-guanosine	PR 3630	≥97%	100 mg; 1 g
N2-Ethyl-2'-deoxyguanosine	PR 3700	≥95%	25 mg; 100 mg
5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosine	PR 3701	≥95%	25 mg; 100 mg
8-Oxo-2'-deoxyguanosine	PR 3710	≥97%	25 mg; 250 mg
8-Oxo-N2-isobutyryl-2'-deoxyguanosine	PR 3720	≥90%	100 mg; 1 g
N2-Isobutyl-2'-deoxyguanosine	PR 3745	≥97%	10 mg; 100 mg
N1-Methyl-2'-deoxyguanosine	PR 3748	≥97%	25 mg; 1 g
N2-Methyl-2'-deoxyguanosine	PR 3750	≥97%	25 mg; 100 mg
O6-Methyl-2'-deoxyguanosine	PR 3755	≥90%	5 mg; 25 mg
6-Thio-2'-deoxyguanosine	PR 3845	≥97%	10 mg; 100 mg
7-Methyl-7-deaza-2'deoxyguanosine	PRA 10042	≥97%	10 mg; 50 mg
2'-Deoxypseudoguanosine	PRA 10103	≥97%	10 mg; 50 mg
2'-Deoxypseudoisoguanosine	PRA 10104	≥97%	10 mg; 100 mg
8-Aza-7-deaza-2'-deoxyguanosine	PRA 10170	≥95%	10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one	PRA 10175	≥95%	10 mg; 100 mg
2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine	PR 3090	≥97%	250 mg; 1 g
2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine	PR 3110	≥95%	250 mg; 1 g
2-Amino-N2-O-methyladenosine	PR 3150	≥97%	1 g; 10 g
2',3'-Di-O-methyladenosine	PR 3540	≥97%	100 mg; 1 g
5'-O-(Dimethoxytrityl)-2'-O-methylinosine	PR 3640	≥97%	1 g;
N6-Methyl-2'-O-Methyladenosine	PR 3733	≥97%	50 mg; 100 mg
2'-O-Methyladenosine	PR 3734	≥97%	1 g;
2'-O-Methylguanosine	PR 3760	≥97%	1 g; 10 g
2'-O-Methylinosine	PR 3770	≥97%	500 mg; 1 g
N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine	PY 7010	≥95%	0 g DISCONTINUED;
N4-Acetyl-5'-methyl-2'-O-methylcytidine	PY 7020	≥97%	0 g DISCONTINUED;
N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine	PY 7100	≥95%	100 mg; 1 g
N4-Benzoyl-2'-O-methylcytidine	PY 7110	≥97%	500 mg; 1 g
3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine	PY 7290	≥95%	500 mg; 1 g
3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridine	PY 7300	≥97%	50 mg; 250 mg
3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridine	PY 7320	≥97%	500 mg; 1 g
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidine	PY 7350	≥97%	0 DISCONTINUED;
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine	PY 7360	≥97%	0 DISCONTINUED;
N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidine	PY 7370	≥97%	0 DISCONTINUED;
5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridine	PY 7420	≥95%	100 mg; 500 mg
5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridine	PY 7460	≥97%	50 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridine	PY 7470	≥97%	100 mg; 1 g
5'-O-(Dimethoxytrityl)-2'-O-methyluridine	PY 7480	≥97%	500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine	PY 7500	≥95%	25 mg; 100 mg
5-Fluoro-2'-O-methyluridine	PY 7570	≥97%	50 mg; 100 mg
5-Fluoro-2'-O-methyl-4-thiouridine	PY 7575	≥97%	10 mg; 100 mg
5-Fluoro-2'-O-methyl-4-(methylithio)uridine	PY 7577	≥97%	10 mg; 100 mg
5-Iodo-2'-O-methylcytidine	PY 7620	≥90%	20 mg; 100 mg
5-Iodo-2'-O-methyluridine	PY 7630	≥97%	100 mg; 1 g
2'-O-Methylcytidine	PY 7636	≥97%	1 g; 5 g
5-Methyl-2'-O-methylcytidine	PY 7640	≥97%	100 mg; 500 mg
5-Methyl-2'-O-methyluridine	PY 7650	≥97%	100 mg; 1 g
5-(1-Propynyl)-2'-O-methylcytidine	PY 7660	≥95%	10 mg; 50 mg
5-(1-Propynyl)-2'-O-methyluridine	PY 7670	≥97%	10 mg; 25 mg
2'-O-Methyluridine	PY 7690	≥97%	5 g;
5'-O-Acetyl-3'-azido-N2-palmitoyl-2',3'-dideoxy-guanosine	PR 3000	≥97%	25 mg; 250 mg
3'-Azido-N6-benzoyl-2',3'-dideoxyadenosine	PR 3200	≥90%	50 mg; 250 mg
3'-Azido-2',3'-dideoxyadenosine	PR 3210	≥97%	10 mg; 25 mg
3'-Azido-2',3'-dideoxyguanosine	PR 3220	≥97%	10 mg; 25 mg
3'-Azido-3'-deoxythymidine (AZT)	PY 7065	≥97%	500 mg; 1 g
3'-Azido-3'-deoxy-5'-O-methylthymidine	PY 7075	≥97%	0 g DISCONTINUED;
3'-Azido-2',3'-dideoxy-5-bromouridine	PY 7286	≥97%	10 mg; 50 mg
N6-Benzoyl-3'-deoxyadenosine	PR 3240	≥97%	100 mg; 1 g
N6-Benzoyl-5'-O-(dimethoxytrityl)-3'-deoxyadenosine	PR 3250	≥97%	100 mg; 1 g
3'-Deoxyadenosine	PR 3430	≥97%	10 mg; 100 mg
3'-Deoxyguanosine	PR 3460	≥97%	10 mg; 100 mg
5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-3'-deoxyguanosine	PR 3590	≥97%	100 mg; 1 g
N2-(Dimethylaminomethylidene)-3'-deoxyguanosine	PR 3690	≥97%	20 mg; 100 mg
2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridine	PY 7000	≥97%	500 mg; 1 g
N4-Benzoyl-3'-deoxycytidine	PY 7080	≥97%	20 mg; 100 mg
3'-Deoxycytidine	PY 7220	≥97%	20 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridine	PY 7240	≥95%	25 mg; 100 mg
5-Methyl-3'-deoxyuridine	PY 7260	≥95%	20 mg; 50 mg
5'-O-(Dimethoxytrityl)-5,6-dihydro-2'-deoxyuridine	PY 7230	≥97%	100 mg;
5,6-Dihydro-2'-deoxyuridine	PY 7330	≥97%	100 mg;
(5S)-5,6-Dihydrothymidine	PY 7340	≥97%	20 mg; 100 mg
(5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidine	PY 7390	≥97%	100 mg;
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine	PY 7360	≥97%	0 DISCONTINUED;
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidine	PY 7400	≥97%	100 mg; 500 mg
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridine	PY 7490	≥95%	50 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine	PY 7500	≥95%	25 mg; 100 mg
5-(1-Propynyl)-2'-O-methylcytidine	PY 7660	≥95%	10 mg; 50 mg
5-(1-Propynyl)-2'-O-methyluridine	PY 7670	≥97%	10 mg; 25 mg
5-(1-Propynyl)-2'-deoxycytidine	PY 7700	≥90%	5 mg; 10 mg
5-(1-Propynyl)-2'-deoxyuridine	PY 7710	≥97%	100 mg; 1 g
2-Amino-6-chloro-9-(β-D-2-deoxyribofuranosyl)purine	PR 3040	≥97%	1 g;
2-Amino-6-chloro-9-(3,5-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purine	PR 3045	≥95%	1 g;
2-Amino-6-chloro-9-(β-D-ribofuranosyl)purine	PR 3050	≥95%	5 g; 25 g
6-Chloro-9-(β-D-2-deoxyribofuranosyl)purine	PR 3370	≥97%	100 mg; 1 g
6-Chloro-9-(3,5-O-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purine	PR 3380	≥90%	100 mg; 1 g
6-Chloro-9-(5-O-dimethoxytrityl-β-D-2-deoxyribofuranosyl)purine	PR 3390	≥97%	0 g;
6-Chloro-9-(β-D-ribofuranosyl)purine	PR 3400	≥97%	5 g; 10 g
Adenosine	PR 3005	≥97%	100 g; 1 kg
8-Methyladenosine	PR 3007	≥95%	25 mg; 100 mg
Vidarabine	PR 3008	≥97%	1 g; 5 g
2-Aminoadenosine (2,6-Diaminopurine riboside)	PR 3030	≥97%	2 g; 10 g
N1-Methyladenosine hydroiodide	PR 3032	≥95%	100 mg; 1 g
2-Methyladenosine	PR 3035	≥97%	10 mg; 25 mg
5'-Chloro-5'-deoxyadenosine	PR 3360	≥97%	100 mg; 1 g
N6-Methyladenosine	PR 3732	≥97%	100 mg; 1 g
N6-Methyl-2'-O-Methyladenosine	PR 3733	≥97%	50 mg; 100 mg
3-Deaza-3-methyl-2'-deoxyadenosine	PRA 10013	≥97%	10 mg; 25 mg
7-Deazaadenosine (tubercidin)	PRA 10035	≥97%	10 mg; 100 mg
5-Iodo-2'-deoxytubercidin	PRA 10036	≥95%	10 mg; 50 mg
2-Amino-4-chloro-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidine	PRA 10000	≥97%	100 mg; 1 g
2-Amino-4-methoxy-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidine	PRA 10005	≥97%	500 mg; 1 g
4-Chloro-1-(β-D-2-deoxyribofuranosyl)imidazo[4,5-C]pyridine	PRA 10006	≥90%	25 mg; 100 mg
8-Azaadenosine	PRA 10007	≥97%	20 mg;
8-Aza-7-deaza-2'-deoxyadenosine (4-Amino-1-(2-deoxyribofuranosyl)pyrazolo[3,4-d]-pyrimidine)	PRA 10008	≥95%	10 mg; 100 mg
4-Chloro-1-(3,5-di-O-toluoyl-2-deoxy-β-D-ribofuranosyl)pyrazolo[3,4-d]pyrimidine	PRA 10009	≥95%	100 mg; 1 g
N6-Benzoyl-7-deaza-2'-deoxyadenosine	PRA 10010	≥97%	100 mg; 1 g
Allopurinol riboside	PRA 10011	≥97%	25 mg; 1 g
5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosine	PRA 10019	≥97%	500 mg; 1 g
N6-Benzoyl-5'-O-(dimethoxytrityl)-7-deaza-2'-deoxyadenosine	PRA 10020	≥97%	100 mg; 1 g
3-Deaza-2'-deoxyadenosine	PRA 10025	≥97%	25 mg; 100 mg
7-Deaza-2'-deoxyadenosine	PRA 10030	≥97%	100 mg; 1 g
7-Deazaadenosine (tubercidin)	PRA 10035	≥97%	10 mg; 100 mg
5-Iodo-2'-deoxytubercidin	PRA 10036	≥95%	10 mg; 50 mg
7-Deaza-2'-deoxyguanosine	PRA 10040	≥97%	100 mg; 1 g
7-Deazaguanosine	PRA 10045	≥97%	10 mg; 100 mg
7-Deaza-2'-deoxyxanthosine	PRA 10050	≥97%	50 mg; 100 mg
5'-O-(Dimethoxytrityl)-7-deaza-2'-deoxyxanthosine	PRA 10055	≥97%	100 mg; 1 g
1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole	PRA 10060	≥97%	100 mg; 1 g
1-(β-D-2-Deoxyribofuranosyl)-4-methylindole	PRA 10070	≥97%	0 g;
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindole	PRA 10080	≥97%	0 g;
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindole	PRA 10090	≥97%	100 mg; 1 g
5-Iodotubercidin	PRA 10095	≥90%	5 mg; 25 mg
5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-7-deaza-2'-deoxyguanosine	PRA 10100	≥97%	100 mg; 1 g
N2-(Dimethylaminomethylidene)-7-deaza-2'-deoxyguanosine	PRA 10110	≥97%	100 mg; 1 g
Sangivamycin	PRA 10140	≥97%	10 mg; 25 mg
Toyocamycin	PRA 10150	≥97%	10 mg; 100 mg
Triciribine	PRA 10160	≥97%	10 mg;
Tricyclic Nucleoside Phosphate	PRA 10162	≥95%	10 mg;
8-Aza-7-deaza-2'-deoxyguanosine	PRA 10170	≥95%	10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one	PRA 10175	≥95%	10 mg; 100 mg
Formycin A	PYA 11001	≥97%	10 mg;
Formycin B	PYA 11002	≥97%	10 mg;
dNaM	FC 8110	≥97%	25 mg; 100 mg
9-Deaza-2'-deoxyguanosine	PRA 10120	≥97%	10 mg; 100 mg
9-Deazaguanosine	PRA 10130	≥97%	10 mg; 100 mg
2-Chloro-6-(β-D-2-deoxyribofuranosyl)-3,5-diaminopyrazine	PYA 11000	≥97%	10 mg; 25 mg
Formycin A	PYA 11001	≥97%	10 mg;
Formycin B	PYA 11002	≥97%	10 mg;
Pyrazofurin	PYA 11004	≥97%	10 mg;
2'-Deoxypseudoisocytidine	PYA 11005	≥97%	10 mg; 100 mg
2'-Deoxypseudouridine	PYA 11010	Purity: ≥97%	25 mg;
5'-O-(Dimethoxytrityl)-N-(dimethylamino) methylidene-2'-deoxypseudoisocytidine	PYA 11035	Purity: ≥97%	50 mg; 100 mg
1,3-Dimethyl-2'-deoxypseudouridine	PYA 11040	≥97%	10 mg; 100 mg
1,3-Dimethylpseudouridine	PYA 11050	≥97%	10 mg; 50 mg
N1-Methylpseudouridine	PYA 11052	≥95%	10 mg; 50 mg
N3-Methylpseudouridine	PYA 11054	≥97%	10 mg; 25 mg
Showdomycin	PYA 11056	≥97%	10 mg;
Pseudoisocytidine hydrochloride	PYA 11060	≥97%	10 mg; 100 mg
Pseudothymidine	PYA 11070	≥97%	10 mg; 100 mg
Pseudouridine	PYA 11080	≥97%	10 mg; 50 mg
3'-O-(t-Butyldimethylsilyl)-5'-oxo-2'-deoxy-8,5'-cycloadenosine	PR 3350	≥97%	10 mg;
(5'S)-8,5'-Cycloadenosine	PR 3410	≥97%	10 mg; 100 mg
(5'S)-2'-Deoxy-8,5'-cycloadenosine	PR 3420	≥97%	10 mg;
5'-Deoxy-8,5'-cycloadenosine	PR 3440	≥97%	10 mg; 100 mg
2',5'-Dideoxy-8,5'-cycloadenosine	PR 3500	≥97%	10 mg;
2',3'-O-Isopropylidene-5'-oxo-8,5'-cycloadenosine	PR 3730	≥97%	10 mg; 100 mg
5'-Oxo-8,5'-cycloadenosine	PR 3800	≥97%	10 mg; 100 mg
5'-Oxo-2'-deoxy-8,5'-cycloadenosine	PR 3810	≥97%	10 mg;
N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine	PY 7010	≥95%	0 g DISCONTINUED;
N4-Acetyl-5'-methyl-2'-O-methylcytidine	PY 7020	≥97%	0 g DISCONTINUED;
N4-Benzoyl-5-(furan-2-yl)-2'-deoxycytidine	PY 7054	≥97%	25 mg; 100 mg
N4-Benzoyl-3'-deoxycytidine	PY 7080	≥97%	20 mg; 100 mg
N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine	PY 7100	≥95%	100 mg; 1 g
N4-Benzoyl-2'-O-methylcytidine	PY 7110	≥97%	500 mg; 1 g
5-Bromo-2'-deoxycytidine	PY 7115	≥97%	1 g; 10 g
Cytidine	PY 7215	≥97%	50 g; 500 g
2'-Deoxycytidine	PY 7216	≥97%	10 g; 50 g
2'-Deoxycytidine Hydrochloride	PY 7217	≥97%	5 g; 50 g
5'-Azido-2',5'-dideoxycytidine	PY 7219	≥97%	25 mg; 100 mg
3'-Deoxycytidine	PY 7220	≥97%	20 mg; 100 mg
N4-Ethyl-2'-deoxycytidine	PY 7245	≥97%	100 mg; 250 mg
5-Methyl-2'-deoxyisocytidine	PY 7255	≥95%	500 mg; 1 g
6-(β-D-2-Deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one	PY 7270	≥97%	20 mg; 50 mg
2',3'-Dideoxycytidine	PY 7325	≥95%	50 mg; 100 mg
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidine	PY 7350	≥97%	0 DISCONTINUED;
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine	PY 7360	≥97%	0 DISCONTINUED;
N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidine	PY 7370	≥97%	0 DISCONTINUED;
6-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one	PY 7380	≥97%	50 mg;
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidine	PY 7400	≥97%	100 mg; 500 mg
5-O-(Dimethoxytrityl)-N4-dimethylaminomethylidene-5-iodo-2'-deoxycytidine	PY 7410	≥97%	100 mg;
6-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido[4,5-c][1,2]oxazin-7-one	PY 7540	≥95%	250 mg; 500 mg
Cytidin-5-yl-methanesulfonate sodium salt hydrate	PY 7586	≥95%	50 mg; 100 mg
5-[(2-Cyanoethoxy)methyl]-2'-deoxycytidine	PY 7587	≥97%	10 mg; 50 mg
5-Hydroxymethyl-2'-deoxycytidine	PY 7588	≥97%	50 mg; 100 mg
5-Formyl-2'-deoxycytidine	PY 7589	≥97%	5 mg; 10 mg
5-Carboethoxy-2'-deoxycytidine	PY 7592	≥95%	25 mg; 100 mg
2'-Deoxycytidine-5-carboxylic acid, sodium salt	PY 7593	≥95%	25 mg; 100 mg
5-Hydroxy-2'-deoxycytidine	PY 7595	≥95%	25 mg; 250 mg
5-Hydroxymethylcytidine	PY 7596	≥97%	50 mg; 100 mg
Cytidine-5-carboxylic acid, sodium salt	PY 7598	≥97%	10 mg; 50 mg
5-Formylcytidine	PY 7599	≥97%	5 mg; 10 mg
5-Iodo-2'-deoxycytidine	PY 7607	≥97%	2 g; 10 g
5-Iodocytidine	PY 7609	≥97%	5 g;
5-Iodo-2'-O-methylcytidine	PY 7620	≥90%	20 mg; 100 mg
5-Methyl-2'-deoxycytidine Hydrochloride	PY 7635	≥97%	0.25 g; 1 g
2'-O-Methylcytidine	PY 7636	≥97%	1 g; 5 g
5-Methylcytidine	PY 7637	≥97%	1 g; 5 g
N4-Methylcytidine	PY 7638	≥97%	25 mg; 100 mg
5-Methyl-2'-O-methylcytidine	PY 7640	≥97%	100 mg; 500 mg
6-Methylcytidine	PY 7641	≥97%	10 mg; 25 mg
5-(1-Propynyl)-2'-O-methylcytidine	PY 7660	≥95%	10 mg; 50 mg
5-(1-Propynyl)-2'-deoxycytidine	PY 7700	≥90%	5 mg; 10 mg
2-Thiocytidine	PY 7721	≥97%	10 mg; 100 mg
2-Thio-2'-deoxycytidine	PY 7723	≥95%	10 mg; 100 mg
3'-Deoxy-3',4'-didehydrocytidine	PY 7790	≥95%	10 mg; 25 mg
Pyrrolo-dC	PYA 11090	≥95%	10 mg; 100 mg
6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-one	PYA 11092	≥97%	10 mg; 100 mg
3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-one	PYA 11095	≥95%	100 mg; 1 g
3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dione	PYA 11100	≥95%	10 mg; 100 mg
3,N4-Etheno-2'-deoxycytidine	PYA 11130	≥97%	100 mg; 500 mg
N6-Benzoyl-8-oxo-2'-deoxyadenosine	PR 3270	≥97%	100 mg; 1 g
(5'S)-8,5'-Cycloadenosine	PR 3410	≥97%	10 mg; 100 mg
(5'S)-2'-Deoxy-8,5'-cycloadenosine	PR 3420	≥97%	10 mg;
5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosine	PR 3610	≥97%	100 mg; 1 g
8-Oxo-2'-deoxyadenosine	PR 3705	≥95%	25 mg; 250 mg
8-Oxo-2'-deoxyguanosine	PR 3710	≥97%	25 mg; 250 mg
8-Oxo-N2-isobutyryl-2'-deoxyguanosine	PR 3720	≥90%	100 mg; 1 g
8-Hydroxyguanosine	PR 3795	≥97%	10 mg; 100 mg
8-Aza-7-deaza-2'-deoxyguanosine	PRA 10170	≥95%	10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one	PRA 10175	≥95%	10 mg; 100 mg
5-Aza-2'-deoxycytidine	PY 7105	≥95%	25 mg; 100 mg
5,6-Dihydro-5-aza-2'-deoxycytidine	PY 7106	≥97%	25 mg; 100 mg
5,6-Dihydro-2'-deoxyuridine	PY 7330	≥97%	100 mg;
(5S)-5,6-Dihydrothymidine	PY 7340	≥97%	20 mg; 100 mg
5-Hydroxy-2'-deoxycytidine	PY 7595	≥95%	25 mg; 250 mg
5-Hydroxy-2'-deoxyuridine	PY 7597	≥95%	25 mg; 250 mg
5-(2-Hydroxyethyl)-2'-deoxyuridine	PY 7600	≥95%	25 mg; 50 mg
5-Hydroxymethyl-2'-deoxyuridine	PY 7605	≥95%	25 mg; 250 mg
6-Methylcytidine	PY 7641	≥97%	10 mg; 25 mg
Nap-dU	PY 7735	≥97%	10 mg; 25 mg
NPOM-Caged deoxythymidine	PY 7795	≥97%	25 mg; 100 mg
3,N4-Etheno-2'-deoxycytidine	PYA 11130	≥97%	100 mg; 500 mg
Pyrrolo-dC	PYA 11090	≥95%	10 mg; 100 mg
6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-one	PYA 11092	≥97%	10 mg; 100 mg
3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-one	PYA 11095	≥95%	100 mg; 1 g
3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dione	PYA 11100	≥95%	10 mg; 100 mg
8-18O-Hydroxyguanosine	IOPR 3795	≥95%	2 mg; 5 mg
2'-Deoxyisoguanosine	PR 3465	≥97%	10 mg; 100 mg
5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosine	PR 3701	≥95%	25 mg; 100 mg
N2-Dimethylguanosine	PR 3702	≥97%	10 mg; 100 mg
Guanosine	PR 3703	≥97%	100 g; 500 g
Isoguanosine	PR 3735	≥97%	10 mg; 50 mg
O6-Methylguanosine	PR 3757	≥97%	25 mg; 100 mg
2'-O-Methylguanosine	PR 3760	≥97%	1 g; 10 g
7-Methyl-6-thioguanosine	PR 3790	≥75%	25 mg; 100 mg
8-Bromoguanosine	PR 3796	≥97%	0 g;
8-Benzyloxyguanosine	PR 3797	≥95%	100 mg; 1 g
7-Methyl-7-deaza-2'deoxyguanosine	PRA 10042	≥97%	10 mg; 50 mg
7-Deazaguanosine	PRA 10045	≥97%	10 mg; 100 mg
5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione	PRA 10047	≥97%	10 mg; 100 mg
2'-Deoxypseudoguanosine	PRA 10103	≥97%	10 mg; 50 mg
2'-Deoxypseudoisoguanosine	PRA 10104	≥97%	10 mg; 100 mg
1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole	PRA 10060	≥97%	100 mg; 1 g
1-(β-D-2-Deoxyribofuranosyl)-4-methylindole	PRA 10070	≥97%	0 g;
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindole	PRA 10080	≥97%	0 g;
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindole	PRA 10090	≥97%	100 mg; 1 g
2'-Deoxy-4-desmethylwyosine	PR 3450	≥95%	100 mg; 500 mg
2'-Deoxyinosine	PR 3463	≥97%	10 g; 100 g
5'-Azido-2',5'-dideoxyinosine	PR 3464	≥97%	5 mg; 25 mg
3',5'-Di-O-acetyl-2'-deoxyinosine	PR 3480	≥97%	1 g;
3',5'-Di-O-acetyl-O6-phenyl-2'-deoxyinosine	PR 3490	≥90%	1 g;
5'-O-(Dimethoxytrityl)-2'-O-methylinosine	PR 3640	≥97%	1 g;
5'-O-(Dimethoxytrityl)-O6-phenyl-2'-deoxyinosine	PR 3660	≥97%	100 mg; 1 g
Inosine	PR 3725	≥97%	100 g; 500 g
2',3'-Dideoxyinosine	PR 3727	≥97%	100 mg; 1 g
2'-O-Methylinosine	PR 3770	≥97%	500 mg; 1 g
7-Methylinosine	PR 3780	≥95%	100 mg; 250 mg
O6-Phenyl-2'-deoxyinosine	PR 3840	≥97%	100 mg; 1 g
2-Fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosine	PR 3842	≥97%	25 mg;
5'-O-Dimethoxytrityl-2-fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosine	PR 3843	≥90%	25 mg; 100 mg
2'-Deoxyisoguanosine	PR 3465	≥97%	10 mg; 100 mg
N6-(Diisobutylaminomethylidene)-2'-deoxyisoguanosine	PR 3510	≥90%	100 mg; 1 g
N6-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosine	PR 3520	≥95%	100 mg; 1 g
N6-(Diisobutylaminomethylidene)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosine	PR 3530	≥90%	100 mg; 1 g
Isoguanosine	PR 3735	≥97%	10 mg; 50 mg
d5SICS	FC 8120	≥97%	25 mg; 100 mg
AICA Riboside (AICAR)	MN 20001	≥97%	0 g (DISCONTINUED);
2',3'-Di-O-methyladenosine	PR 3540	≥97%	100 mg; 1 g
2,6-Bis-O-[2-(4-nitrophenyl)ethyl]-2'-deoxyxanthosine	PR 3692	≥95%	10 mg; 100 mg
5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione	PRA 10047	≥97%	10 mg; 100 mg
8-Aza-7-deaza-2'-deoxyguanosine	PRA 10170	≥95%	10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one	PRA 10175	≥95%	10 mg; 100 mg
3'-Deoxy-3',4'-didehydrocytidine	PY 7790	≥95%	10 mg; 25 mg
NPOM-Caged deoxythymidine	PY 7795	≥97%	25 mg; 100 mg
tC Nucleoside	PYA 11110	≥97%	50 mg; 100 mg
tCnitro Nucleoside	PYA 11115	≥95%	5 mg; 25 mg
2'-Deoxynebularine	PR 3470	Purity: ≥97%	100 mg; 1 g
7-Methylinosine	PR 3780	≥95%	100 mg; 250 mg
7-Methyl-6-thioguanosine	PR 3790	≥75%	25 mg; 100 mg
1-(β-D-2-Deoxyribofuranosyl)-3-nitropyrrole	PYA 11020	≥97%	50 mg;
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3-nitropyrrole	PYA 11030	≥95%	100 mg;
Showdomycin	PYA 11056	≥97%	10 mg;
Formycin A	PYA 11001	≥97%	10 mg;
Formycin B	PYA 11002	≥97%	10 mg;
Pseudouridine	PYA 11080	≥97%	10 mg;
Pyrazofurin	PYA 11004	≥97%	10 mg;
Toyocamycin	PRA 10150	≥97%	10 mg;
7-Deazaadenosine (tubercidin)	PRA 10035	≥97%	10 mg;
Allopurinol riboside	PRA 10011	≥97%	25 mg;
5-Iodotubercidin	PRA 10095	≥90%	5 mg;
Triciribine	PRA 10160	≥97%	10 mg;
Tricyclic Nucleoside Phosphate	PRA 10162	≥95%	10 mg;
5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione	PRA 10047	≥97%	10 mg;
5'-Amino-5'-deoxythymidine	PY 7030	≥97%	25 mg; 50 mg
O2,5'-Anhydrothymidine	PY 7060	≥95%	500 mg; 1 g
3'-Azido-3'-deoxythymidine (AZT)	PY 7065	≥97%	500 mg; 1 g
5'-Azido-5'-deoxythymidine	PY 7070	≥97%	25 mg; 100 mg
3'-Azido-3'-deoxy-5'-O-methylthymidine	PY 7075	≥97%	0 g DISCONTINUED;
3'-O-(t-Butyldimethylsilyl)-5'-deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidine	PY 7120	≥97%	1 g;
3'-O-(t-Butyldimethylsilyl)thymidine	PY 7130	≥95%	500 mg; 1 g
5'-O-(t-Butyldimethylsilyl)thymidine	PY 7140	≥97%	5 g; 10 g
3',5'-bis-O-(t-Butyldimethylsilyl)thymidine	PY 7150	≥97%	1 g; 5 g
3',5'-bis-O-(t-Butyldimethylsilyl)-O4-(2,4,6-triisopropylphenylsulfonyl)thymidine	PY 7160	≥95%	100 mg; 500 mg
S4-(2-Cyanoethyl)-5'-O-(dimethoxytrityl)-4-thiothymidine	PY 7200	≥95%	10 mg; 100 mg
S4-(2-Cyanoethyl)-4-thiothymidine	PY 7210	≥95%	10 mg; 100 mg
5'-Deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidine	PY 7250	≥97%	1 g;
3'-Deoxythymidine	PY 7277	≥95%	50 mg; 100 mg
1-(3,5-Di-O-acetyl-β-D-deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)-5-methylpyrmidin-2-one	PY 7315	≥90%	1 g; 10 g
2',3'-Didehydro-3'-deoxythymidine	PY 7328	≥95%	10 mg; 100 mg
(5S)-5,6-Dihydrothymidine	PY 7340	≥97%	20 mg; 100 mg
(5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidine	PY 7345	≥95%	10 mg; 25 mg
(5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidine	PY 7390	≥97%	100 mg;
5'-O-(Dimethoxytrityl)-N3/O4-(toluoyl)-2-thiothymidine	PY 7510	≥97%	50 mg; 100 mg
2-O-Ethylthymidine	PY 7561	≥97%	500 mg; 1 g
5'-Iodo-5'-deoxythymidine	PY 7610	≥97%	250 mg; 1 g
5'-O-Methylthymidine	PY 7680	≥95%	50 mg; 100 mg
2-Thiothymidine	PY 7725	≥95%	20 mg; 100 mg
Thymidine	PY 7727	≥97%	25 g; 250 g
5'-O-(p-Toluenesulfonyl)thymidine	PY 7740	≥97%	5 g;
3-(2-Cyanoethyl)thymidine	PY 7742	≥95%	10 mg; 25 mg
5'-Trifluoroacetamido-5'-deoxythymidine	PY 7750	≥97%	50 mg;
NPOM-Caged deoxythymidine	PY 7795	≥97%	25 mg; 100 mg
6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-one	PYA 11055	≥97%	5 mg; 25 mg
6-Azathymidine	PYA 11058	≥95%	25 mg; 100 mg
NPOM-Caged-dT CEP	BA 0317	≥95%	100 µmol; 0.25 g
5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine	PY 7040	≥97%	100 mg; 1 g
5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine	PY 7050	≥90%	100 mg; 1 g
3'-Azido-3'-deoxy-5'-O-methylthymidine	PY 7075	≥97%	0 g DISCONTINUED;
(E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridine	PY 7170	≥97%	1 g;
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridine	PY 7180	≥97%	500 mg; 1 g
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide Ester	PY 7190	≥97%	100 mg; 1 g
(5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidine	PY 7345	≥95%	10 mg; 25 mg
5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridine	PY 7520	≥97%	100 mg; 1 g
5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine	PY 7530	≥97%	100 mg; 1 g
1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-one	PY 7550	≥95%	100 mg; 1 g
3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridine	PY 7560	≥95%	500 mg; 1 g
5-(2-Hydroxyethyl)-2'-deoxyuridine	PY 7600	≥95%	25 mg; 50 mg
3-(2-Cyanoethyl)thymidine	PY 7742	≥95%	10 mg; 25 mg
5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridine	PY 7754	≥95%	100 mg; 1 g
5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridine	PY 7760	≥90%	100 mg; 1 g
5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine	PY 7770	≥95%	100 mg; 1 g
NPOM-Caged deoxythymidine	PY 7795	≥97%	25 mg; 100 mg
6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-one	PYA 11055	≥97%	5 mg; 25 mg
5-Ethynyl uridine CEP	BA 0353	≥90%	100 µmol; 0.25 g
2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridine	PY 7000	≥97%	500 mg; 1 g
5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine	PY 7040	≥97%	100 mg; 1 g
5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine	PY 7050	≥90%	100 mg; 1 g
5-(Furan-2-yl)-2'-deoxyuridine	PY 7053	≥97%	25 mg; 100 mg
1-(β-D-2-Deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)pyrimidin-2-one	PY 7055	≥97%	20 mg; 100 mg
5-Bromo-2'-deoxyuridine	PY 7117	≥97%	10 g; 25 g
5-Bromouridine	PY 7118	≥95%	5 g;
(E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridine	PY 7170	≥97%	1 g;
(E)-5-(2-Carbomethoxyvinyl)uridine	PY 7172	≥97%	25 mg; 250 mg
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridine	PY 7180	≥97%	500 mg; 1 g
(E)-5-(2-Carboxyvinyl)uridine	PY 7185	≥97%	1 g;
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide Ester	PY 7190	≥97%	100 mg; 1 g
S4-(2-Cyanoethyl)-4-thio-2'-deoxyuridine	PY 7212	≥95%	10 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridine	PY 7240	≥95%	25 mg; 100 mg
5-Methyl-3'-deoxyuridine	PY 7260	≥95%	20 mg; 50 mg
2'-Deoxyuridine	PY 7275	≥97%	25 g; 100 g
3',5'-Di-O-acetyl-5-fluoro-2'-deoxyuridine	PY 7280	≥95%	100 mg; 500 mg
3'-Azido-2',3'-dideoxy-5-bromouridine	PY 7286	≥97%	10 mg; 50 mg
3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine	PY 7290	≥95%	500 mg; 1 g
3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridine	PY 7300	≥97%	50 mg; 250 mg
3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridine	PY 7310	≥97%	20 mg; 50 mg
3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridine	PY 7320	≥97%	500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridine	PY 7420	≥95%	100 mg; 500 mg
5'-O-(Dimethoxytrityl)-5-iodo-2'-deoxyuridine	PY 7450	≥97%	500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridine	PY 7460	≥97%	50 mg; 100 mg
5-Methoxymethyl-2'-deoxyuridine	PY 7465	≥95%	10 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridine	PY 7470	≥97%	100 mg; 1 g
5'-O-(Dimethoxytrityl)-2'-O-methyluridine	PY 7480	≥97%	500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridine	PY 7490	≥95%	50 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine	PY 7500	≥95%	25 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridine	PY 7520	≥97%	100 mg; 1 g
5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine	PY 7530	≥97%	100 mg; 1 g
1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-one	PY 7550	≥95%	100 mg; 1 g
3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridine	PY 7560	≥95%	500 mg; 1 g
5-Ethynyl-2'-deoxyuridine	PY 7562	≥97%	25 mg; 100 mg
5-Ethynyl uridine	PY 7563	≥97%	10 mg; 100 mg
5-Fluoro-2'-deoxyuridine	PY 7565	≥97%	100 mg; 1 g
5-Fluoro-2'-O-methyluridine	PY 7570	≥97%	50 mg; 100 mg
5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridine	PY 7580	≥97%	25 mg; 100 mg
5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine	PY 7590	≥95%	25 mg; 100 mg
5-Hydroxy-2'-deoxyuridine	PY 7597	≥95%	25 mg; 250 mg
5-(2-Hydroxyethyl)-2'-deoxyuridine	PY 7600	≥95%	25 mg; 50 mg
5-Acetoxymethyl-2'-deoxyuridine	PY 7604	≥97%	25 mg; 100 mg
5-Hydroxymethyl-2'-deoxyuridine	PY 7605	≥95%	25 mg; 250 mg
2'-Fluoro-5'-iodo deoxyuridine	PY 7612	≥95%	100 mg;
5-Iodo-2'-deoxyuridine	PY 7615	≥97%	10 g; 25 g
5-Iodo-2'-O-methyluridine	PY 7630	≥97%	100 mg; 1 g
5-Iodouridine	PY 7632	≥95%	5 g; 25 g
5-Methyl-2'-O-methyluridine	PY 7650	≥97%	100 mg; 1 g
5-(1-Propynyl)-2'-O-methyluridine	PY 7670	≥97%	10 mg; 25 mg
2'-O-Methyluridine	PY 7690	≥97%	5 g;
3-Methyluridine	PY 7694	≥97%	25 mg; 100 mg
5-Methyluridine	PY 7695	≥97%	200 mg; 1 g
5-(1-Propynyl)-2'-deoxyuridine	PY 7710	≥97%	100 mg; 1 g
5-(Propargyloxy)-2'-deoxyuridine	PY 7712	≥95%	10 mg; 100 mg
Zebularine	PY 7715	≥97%	10 mg; 25 mg
3',5'-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)-2'-deoxyuridine	PY 7720	≥90%	500 mg; 1 g
2-Thiouridine	PY 7724	≥97%	25 mg; 100 mg
5'-O-(p-Toluenesulfonyl)-2'-deoxyuridine	PY 7730	≥97%	1 g; 5 g
5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridine	PY 7754	≥95%	100 mg; 1 g
5-[3-(Trifluoroacetamido)-1-(E)-propenyl]uridine	PY 7758	≥97%	100 mg; 1 g
5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridine	PY 7760	≥90%	100 mg; 1 g
5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine	PY 7770	≥95%	100 mg; 1 g
5-[N-(6-(Trifluoracetamido)hexyl)-(E)-acrylamido]uridine	PY 7775	≥97%	100 mg; 1 g
Uridine	PY 7780	≥97%	100 g; 500 g
2'3'-O-Isopropylidene uridine	PY 7781	≥97%	5 g; 25 g
5-Hydroxymethyl uridine	PY 7782	≥97%	50 mg; 100 mg
5-Methoxyuridine	PY 7783	≥97%	10 mg; 50 mg
6-Aza-2'-deoxyuridine	PYA 11057	≥95%	50 mg; 100 mg

" data-original="http://nordic.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Berry & Associates全系列修饰核苷酸"> 艾美捷科技代理Berry & Associates全系列修饰核苷酸

...

阅读详情

Immunostar公司主要制造和销售各种免疫多克隆和单克隆神经学的一抗。

ImmunoStar is the original manufacturer of primary polyclonal and monoclonal antibodies. We take pride in selling to neuroscience researchers at a high-titer and fair price. Since 1975, we have earned a reputation for trusted antibodies that work every time.

Our quality reputation has been validated in over seven thousand citations in biomedical literature of ImmunoStar antibodies. You can find and search them all on our Publications page. This user-friendly database can be searched by antibody, research area, species reactivity, or keyword. ImmunoStar’s core antibodies were previously sold and cited under the names Diasorin, Incstar, and ImmunoNuclear.

Immunostar的主要产品包括：

（1）Antibodies

5-HIAA (5-Hydroxyindoleacetic Acid) Antibody

5-HT (Serotonin) 1A Receptor Antibody

5-HT (Serotonin) 2A Receptor Antibody等

（2）Peptide Controls

5-HT (Serotonin) / BSA Conjugate Control

nNOS:C-Terminal Peptide Control

Opioid Receptor-Mu Peptide Control等

（3）Testimonials

更多详情请联系

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

" data-original="http://nordic.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="ImmunoStar"> ImmunoStar

...

阅读详情

艾美捷科技代理Viagen Biotech品牌。

Molzym公司致力于提供先进的分子生物学工具和解决方案，以支持全球的研究人员、科学家和生物技术公司在生命科学研究、分子诊断和生物制药领域的工作。公司以其对产品质量的严格把控和对客户需求的深刻理解而受到客户的信赖。

Viagen Biotech致力于开发高质量的DNA提取系统和相关试剂，以支持全球的学术研究、生物技术和制药公司的研究工作。DirectPCR® DNA Extraction System（DirectPCR® DNA提取系统）在业界具有很高的口碑。Viagen Biotech公司的核心产品与技术为DirectPCR® DNA Extraction System：这是一种单管系统，用于从小鼠尾巴、耳片、卵黄囊和培养细胞内快速制备DNA。该系统消除了任何溶液转移或开管步骤，从根本上节省了时间和精力。DirectPCR®试剂不仅介导生物样品的快速溶解，还包含有效抑制原油裂解液的抑制活性的PCR抑制剂，同时最大限度地保持完整的基因组DNA的释放。Viagen Biotech公司其他相关产品包括蛋白酶K溶液、E-Prep DNA提取试剂等在内的多种分子生物学试剂；这些试剂广泛应用于分子生物学实验，特别是在DNA提取和纯化过程中。Viagen Biotech的产品适用于需要进行基因分型和遗传分析的实验室。DirectPCR®试剂特别适合于从小鼠等实验动物中提取DNA，用于发育生物学、遗传学研究等领域。

<<<<<< " data-original="http://nordic.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Viagen Biotech品牌"> 艾美捷科技代理Viagen Biotech品牌

...

阅读详情

艾美捷科技特约代理BioPAL全系列产品。

BioPAL公司位于美国马萨诸塞Worcester，服务于生命科学和生物医药行业，主要从事非放射性报告系统的研发、生产、商业化。此外，BioPAL销售用于核磁共振（MRI）的纳米颗粒；BioPAL还提供即用型的细胞标记及示踪产品。

BioPhysics Assay Laboratory (BioPAL, Inc.) is a privately held, for-profit company based in Worcester Massachusetts. The company develops and sells novel tools for the life science and biomedical communities. BioPAL was the first company to commercialize non-radioactive products that use neutron activation technology as the read-out system. The company also develops and sells nanoparticles for applications in magnetic resonance imaging (MRI), magnetic separation applications and tools for time resolved fluorescent technology. BioPAL offers ready-to-use cell labeling and tracking products for cellular therapy research applications.

BioPAL was the first to introduce functional immunoassay technology (FIT) to the research community. The company offers a line of renal diagnostics based on FIT to measure glomerular filtration rate (GFR) and effective renal blood flow (RBF). Most notably is BioPAL's ELISA kit for the measurement of inulin.

BioPAL公司的主要产品包括：

Pre-Clinical Imaging Agents

Kidney Diagnostics

Microspheres for Blood Flow Studies

Dead-Cell Removal Kits - Viahanc

Products for Cellular Therapy Research

" data-original="http://nordic.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技特约代理BioPAL全系列产品"> 艾美捷科技特约代理BioPAL全系列产品

...

阅读详情

Santa Cruz Biotechnology公司是全球最大的抗体生产厂商之一，目前公司提供二万余种研究用的第一抗体，几乎覆盖了目前生命科学研究的各个最新领域，其每种抗体又有多个克隆可以选择，还提供一些对应蛋白标准品及相关产品，如ABC试剂盒，各种标记二抗，Western试剂盒，蛋白分子量Marker，核抽提物等，为免疫学研究工作提供了极大的方便。

更多详情请联系

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

" data-original="http://nordic.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Santa Cruz Biotechnology"> Santa Cruz Biotechnology

...

阅读详情

BioVision公司是世界顶尖的细胞凋亡和信号传导产品生产商，产品包括检测试剂盒，抗体及重组蛋白，涵盖了细胞凋亡、细胞信号传导和细胞因子研究的各个方面。凋亡产品包括Annexin V 试剂盒、半胱天冬氨酸蛋白酶（Caspases）试剂盒及底物和抑制剂、线粒体膜电位试剂盒、梯状DNA 电泳和TUNEL 试剂盒、凋亡诱导剂、凋亡相关抗体和化学品、细胞增殖检测试剂盒等。

BioVision, Inc., is a privately held Life Science company headquartered in the beautiful San Francisco Bay Area. BioVision develops and offers a wide variety of products including assay kits, antibodies, recombinant proteins & enzymes, and other innovative research tools for studying Apoptosis, Metabolism, Cell Proliferation, Cellular Stress, Cell Damage and Repair, Diabetes, Obesity and Metabolic Syndrome, Stem Cell Biology, Gene Regulation, Signal Transduction, etc. BioVision's products are currently being sold in more than 60 countries worldwide.

BioVision公司的主要产品包括：

Antibodies & Supporting Tools

Biochemicals

Cytokines & Growth Factors

ELISA Kits

Enzyme Inhibitors

EZSolution™ Ready-to-Use Products

Fluorescent Proteins

Laboratory accessories

Metabolism Assay Kits

Molecular Biology

Protein A,G,L & Affinity Conjugates

Proteins & Enzymes

Protein Extraction & Purification

Signaling Pathways

按研究领域细分

Apoptosis

Autophagy

Cardiovascular

Cancer

Cell Damage & Oxidative Stress

Cell Proliferation, Viability & Cytotoxicity

Diabetes, Obesity & Metabolic Syndrome

Drug Metabolism & Disposition

Epigenetics

Exosomes

Infectious Diseases

Metabolism

Neuroscience

Proteostasis

Signal Transduction

" data-original="http://nordic.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="BioVision"> BioVision

...

阅读详情

产品包括：

Side-Functionalized Homopolyamino Acids

Poly-L-lysine

Poly-L-glutamic acid

End-Functionalized Homopolyamino Acids

Poly-L-lysine

Poly-L-glutamic acid

Poly-L-arginine

Homopolyamino Acids

Poly-L-lysine

Poly-D-lysine

Poly-D,L-lysine

Poly-L-ornithine

Poly-L-homoarginine

Poly-L-arginine

Poly-L-glutamic acid

Poly-D-glutamic acid

Poly-D,L-glutamic acid

Poly-L-aspartic acid

PEGylated Polyamino Acids

PEG-b-poly-L-lysine

N3-PEG-b-poly-L-lysine

PEG-b-poly-L-glutamic acid

N3-PEG-b-poly-L-glutamic acid

PEG-b-poly-L-aspartic acid

Poly(L-Lys)-b-PEG-b-poly(L-Lys)

Poly(L-Glu)-b-PEG-b-poly(L-Glu)

Poly(L-Asp)-b-PEG-b-poly(L-Asp)

Custom Polyamino Acids

Poly-L-lysine

Poly-D-lysine

Poly-L-glutamic acid

Poly-D,L-glutamic acid

Poly-L-arginine

PEG-b-poly-L-lysine

PEG-b-poly-D-lysine

PEG-b-poly-L-glutamic acid

PEG-b-poly-L-aspartic acid

Poly(L-Glu)-b-PEG-b-poly(L-Glu)

Polyamino Acids For Cell Culture

Poly-L-lysine

Poly-D-lysine

Poly-L-ornithine

" data-original="http://nordic.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Alamanda Polymers"> Alamanda Polymers

...

阅读详情

Celprogen是一家生物技术公司，为心脏病学、肿瘤学、糖尿病和神经病学的再生医学研发干细胞研究和治疗产品。Celprogen的所有生物产品，包括干细胞、癌症干细胞、IPC和包括ECM在内的培养基，均在美国制造和生产。

CELPROGEN is a biotechnology company developing stem cell research and therapeutics products for regenerative medicine in cardiology, oncology, diabetes & neurology. All of Celprogen’s biological products, including stem cells, cancer stem cells, iPC’s & media including ECM’s, are manufactured and produced in the United States of America. CELPROGEN provides novel molecular diagnostics and therapeutic product development solutions for Biotechnology, Pharmaceutical, Invitro diagnostics and academic partnership for drug discovery.

Celprogen公司的主要产品：

3D Culture Systems

Biological Reagents

Cell-Based Assay Kits

Cosmetic

Devices

ExtracellularMatrix

Human Serum Albumin (HSA)

Life Science

Normal Cells

Organ Cultures

Patient-Derived Xenografts [PDX]

Therapeutics

Tumorgenicity

Vaccine Development

Xeno-Free Media

" data-original="http://nordic.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Celprogen"> Celprogen

...

阅读详情

2 3 4 5 6 7 8 9 10 11

城市分站

友情链接 invivoCrown IV0105替换BioXCell BE0089 invivoCrown IV0105替换BioXCell BE0089 invivoCrown IV0105替换BioXCell BE0089 invivoCrown IV0106替换BioXCell BE0090 invivoCrown IV0104替换BioXCell BE0061 invivoCrown IV0113替换BioXCell BE0075 invivoCrown IV0104替换BioXCell BE0061 invivoCrown IV0121替换BioXCell BE0001-1 invivoCrown IV0103替换BioXCell BE0075-1 invivoCrown IV0116替换BioXCell BE0016-2

联系我们

地址：武汉市洪山区光谷大道35号光谷总部国际时代二期1栋1301

电话：13212737804

传真：18372041646

邮箱：sales@amyjet.com

0.2821